KIMBERLY ARMSTRONG: Open Payments
NPI 1508473893 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $36 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $124 |
| Lundbeck LLC | 2 | $38 |
| Novo Nordisk Inc | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: ZERBAXA, REXULTI, Ozempic, JARDIANCE, MOUNJARO, GVOKE HYPOPEN.
Industry payments across LA — which companies pay providers there.
